New York - Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology firm focused on enhancing women’s health, particularly in breast aesthetics and reconstruction, disclosed the achievement of having over 5 million Motiva devices in circulation. This significant milestone highlights the company's dedication to science-driven advancements and demonstrates the ongoing worldwide acceptance of Motiva’s range of products for breast aesthetics and reconstruction.